Lurasidone HCl A Phase 3 Study of Patients With Acute Schizophrenia
Clinical trial NCT00615433 · COMPLETED
Trial details
- NCT number
- NCT00615433
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2009-12-01
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.